According to the statistics of China Medical Materials Association, as of 2014, more than 2,000 mobile medical apps were launched online in China. In 2014, there were a total of 85 investment and financing events in mobile medical companies, most of which were concentrated in registered and medical consultation products, including Baidu, Ali, Jingdong and other giant figures.
In 2015, the mobile medical industry remained hot. The difference is that more companies have turned their attention to the field of chronic disease medical health management. The chronic disease management known as “rich disease†seems to have become the next gold mine for mobile medical treatment.
"Rich disease" is also called "modern civilization disease". It is mainly characterized by over-nutrition caused by eating too well and too fine, plus non-communicable epidemics caused by lack of exercise. The main representative diseases are high blood pressure and high disease. Blood lipids, coronary heart disease, diabetes, etc.
Statistics show that there are currently 260 million people with chronic diseases in China, and they are still increasing at an annual rate of 8.9%. A large number of data indicate that chronic diseases are showing signs of rejuvenation. In the past 20 years, patients with chronic diseases over 40 years old have increased two to three times. High-incidence and high-risk groups have also made the management of "rich diseases" mobile medical apps such as diabetes and cardiovascular diseases the hottest positions in the industry.
Mobile medical APP goes deep into the vertical field of chronic diseases
Unlike the venture capitalists who invested heavily in registered products a year ago, companies that develop chronic disease health management APPs have received very little investment. Although the investment community is still in the wait-and-see stage for health management, it has not affected the enthusiasm of developers, and has taken the lead in vertical fields.
The results of Yicai.com show that there are a large number of medical management APP products in the fields of diabetes, heart disease, respiratory system, hypertension, hyperlipidemia, male urinary system, lumbar disease, dental, etc., especially diabetes and hypertension. Most of the search results of some APP products are as follows:
According to Ai Media Consulting's "2012-2013 China Mobile Medical Market Annual Report" data shows that the market size of mobile medical routine services reached 1.13 billion yuan in 2012, and the market size of mobile diagnostic services (only online assisted diagnosis) reached 220 million. Yuan, treatment services (excluding hospitalization treatment) market size reached 170 million yuan. Ai Media also expects that by 2017, the market size of mobile medical routine services will reach 7.34 billion yuan.
Despite the attractiveness of “Qian Jingâ€, mobile health management of chronic diseases still needs to solve important problems such as the mode of transmission (patient privacy hinders communication), payment mode, professionalism and so on. In addition, the same type of products that have mushroomed into the market have become too similar. How to truly find the "pain point" to make a feature has become the primary issue before everyone.
The "Hundred Sugar Battle" in the field of diabetes
According to the statistics of Yicai.com, the input of “diabetes†in the Apple APP Store shows a total of 365 results, of which more than 30 apps related to disease health management. Among them, there are "sugar nurses" who have obtained two rounds of investment and total financing of more than 30 million yuan. In October this year, they got a $15 million Series A round of financing, and there are a large number of "big sugar doctors". "U Sugar Health", "Sugar Nurse", "Glucose Executive", "Micro Sugar", "Spring Rain Sugar Butler" and other APP application products dedicated to diabetes health management.
The reason why everyone is looking at the diabetes market is because China has a huge potential user base. The number of 98.4 million diabetic patients in China ranks first in the world, which means that one in every 15 people in China has diabetes. It is estimated that by 2018, the number of people with diabetes in China will reach 120 million.
In addition, the diabetes-related industry has an annual capacity of more than 400 billion US dollars, which also provides a powerful driving force for mobile medical companies to penetrate the diabetes market.
Regardless of the motive, in the short-term problem of “difficult to see a doctorâ€, the rapid rise of mobile medical products can effectively improve the daily health management effect of “rich and sick†patients, and will be positive for improving the quality of life and strengthening daily rehabilitation. Promotion.
It seems that Internet medical care is not only the spring of the gold digger, but also the spring of the "rich disease" patients.
Short range distance sensors from JRT combine highly precise measurement results with quick and reliable response. Short distance sensor module use single-transmit and single-receive measurement technology and can be used to measure a distance or monitor the slow moving objects. For the laser pointer distance measure, also called optical range sensor, can measure legth, width, depth. Laser rangefinder transducer with rxtx has been widely used to industries.
Laser Distance Sensor Short Range,Short Range Sensors,Oem Laser Distance Sensor,Distance Sensor Laser
Chengdu JRT Meter Technology Co., Ltd , https://www.jrt-measure.com